An antisense strategy for inhibition of human melanoma growth targets the growth factor pleiotrophin

Kapaettu Satyamoorthy, Masahiro Oka, Meenhard Herlyn

    Research output: Contribution to journalArticle

    21 Citations (Scopus)

    Abstract

    A major biological characteristic of metastatic melanomas is their ability to survive in a growth-factor-depleted environment, whereas normal melanocytes die rapidly under such conditions. The increased survival of melanoma cells is due to their production of growth factors for autocrine growth stimulation. Here, we describe a strategy to inhibit pleiotrophin (PTN), a heparin-binding autocrine growth factor for melanoma cells. To target PTN production in melanoma cells, a replication-deficient, recombinant adenovirus was generated to express antisense (AS) PTN at high efficiency. The AS vector induced transcripts that completely inhibited PTN protein production. Melanoma growth was strongly inhibited if the tumor cells were maintained in a three-dimensional environment in soft agar, whereas cell growth was not affected if the tumor cells were grown as a monolayer, suggesting the importance of cell-matrix interactions for the biological activity of this growth factor. The down-regulation of PTN in transduced melanoma cells coincided with the down-regulation of the cell-cycle regulator cyclin E and the up-regulation of the cell-cycle inhibitor p21WAF1/Cip1. Tumor growth in vivo was also delayed by the AS-PTN vector, confirming that PTN is essential for the three-dimensional growth of tumor cells. Our studies demonstrate the importance of assessing potential melanoma antagonists not only on cells grown as monolayers but also in three-dimensional matrices.

    Original languageEnglish
    Pages (from-to)87-93
    Number of pages7
    JournalPigment Cell Research
    Volume13
    Issue numberSUPPL. 8
    Publication statusPublished - 2000

    Fingerprint

    melanoma
    growth factors
    Melanoma
    Intercellular Signaling Peptides and Proteins
    Cells
    Growth
    Tumors
    cells
    Monolayers
    cell cycle
    Neoplasms
    Cell Cycle
    Down-Regulation
    Cyclin E
    melanocytes
    cyclins
    Cell growth
    heparin
    Adenoviridae
    Bioactivity

    All Science Journal Classification (ASJC) codes

    • Cell Biology
    • Agronomy and Crop Science
    • Plant Science
    • Clinical Biochemistry
    • Developmental Biology

    Cite this

    @article{647473df40e940fb8a244df075b533ae,
    title = "An antisense strategy for inhibition of human melanoma growth targets the growth factor pleiotrophin",
    abstract = "A major biological characteristic of metastatic melanomas is their ability to survive in a growth-factor-depleted environment, whereas normal melanocytes die rapidly under such conditions. The increased survival of melanoma cells is due to their production of growth factors for autocrine growth stimulation. Here, we describe a strategy to inhibit pleiotrophin (PTN), a heparin-binding autocrine growth factor for melanoma cells. To target PTN production in melanoma cells, a replication-deficient, recombinant adenovirus was generated to express antisense (AS) PTN at high efficiency. The AS vector induced transcripts that completely inhibited PTN protein production. Melanoma growth was strongly inhibited if the tumor cells were maintained in a three-dimensional environment in soft agar, whereas cell growth was not affected if the tumor cells were grown as a monolayer, suggesting the importance of cell-matrix interactions for the biological activity of this growth factor. The down-regulation of PTN in transduced melanoma cells coincided with the down-regulation of the cell-cycle regulator cyclin E and the up-regulation of the cell-cycle inhibitor p21WAF1/Cip1. Tumor growth in vivo was also delayed by the AS-PTN vector, confirming that PTN is essential for the three-dimensional growth of tumor cells. Our studies demonstrate the importance of assessing potential melanoma antagonists not only on cells grown as monolayers but also in three-dimensional matrices.",
    author = "Kapaettu Satyamoorthy and Masahiro Oka and Meenhard Herlyn",
    year = "2000",
    language = "English",
    volume = "13",
    pages = "87--93",
    journal = "Pigment Cell and Melanoma Research",
    issn = "1755-1471",
    publisher = "Wiley-Blackwell",
    number = "SUPPL. 8",

    }

    An antisense strategy for inhibition of human melanoma growth targets the growth factor pleiotrophin. / Satyamoorthy, Kapaettu; Oka, Masahiro; Herlyn, Meenhard.

    In: Pigment Cell Research, Vol. 13, No. SUPPL. 8, 2000, p. 87-93.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - An antisense strategy for inhibition of human melanoma growth targets the growth factor pleiotrophin

    AU - Satyamoorthy, Kapaettu

    AU - Oka, Masahiro

    AU - Herlyn, Meenhard

    PY - 2000

    Y1 - 2000

    N2 - A major biological characteristic of metastatic melanomas is their ability to survive in a growth-factor-depleted environment, whereas normal melanocytes die rapidly under such conditions. The increased survival of melanoma cells is due to their production of growth factors for autocrine growth stimulation. Here, we describe a strategy to inhibit pleiotrophin (PTN), a heparin-binding autocrine growth factor for melanoma cells. To target PTN production in melanoma cells, a replication-deficient, recombinant adenovirus was generated to express antisense (AS) PTN at high efficiency. The AS vector induced transcripts that completely inhibited PTN protein production. Melanoma growth was strongly inhibited if the tumor cells were maintained in a three-dimensional environment in soft agar, whereas cell growth was not affected if the tumor cells were grown as a monolayer, suggesting the importance of cell-matrix interactions for the biological activity of this growth factor. The down-regulation of PTN in transduced melanoma cells coincided with the down-regulation of the cell-cycle regulator cyclin E and the up-regulation of the cell-cycle inhibitor p21WAF1/Cip1. Tumor growth in vivo was also delayed by the AS-PTN vector, confirming that PTN is essential for the three-dimensional growth of tumor cells. Our studies demonstrate the importance of assessing potential melanoma antagonists not only on cells grown as monolayers but also in three-dimensional matrices.

    AB - A major biological characteristic of metastatic melanomas is their ability to survive in a growth-factor-depleted environment, whereas normal melanocytes die rapidly under such conditions. The increased survival of melanoma cells is due to their production of growth factors for autocrine growth stimulation. Here, we describe a strategy to inhibit pleiotrophin (PTN), a heparin-binding autocrine growth factor for melanoma cells. To target PTN production in melanoma cells, a replication-deficient, recombinant adenovirus was generated to express antisense (AS) PTN at high efficiency. The AS vector induced transcripts that completely inhibited PTN protein production. Melanoma growth was strongly inhibited if the tumor cells were maintained in a three-dimensional environment in soft agar, whereas cell growth was not affected if the tumor cells were grown as a monolayer, suggesting the importance of cell-matrix interactions for the biological activity of this growth factor. The down-regulation of PTN in transduced melanoma cells coincided with the down-regulation of the cell-cycle regulator cyclin E and the up-regulation of the cell-cycle inhibitor p21WAF1/Cip1. Tumor growth in vivo was also delayed by the AS-PTN vector, confirming that PTN is essential for the three-dimensional growth of tumor cells. Our studies demonstrate the importance of assessing potential melanoma antagonists not only on cells grown as monolayers but also in three-dimensional matrices.

    UR - http://www.scopus.com/inward/record.url?scp=0034564273&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0034564273&partnerID=8YFLogxK

    M3 - Article

    VL - 13

    SP - 87

    EP - 93

    JO - Pigment Cell and Melanoma Research

    JF - Pigment Cell and Melanoma Research

    SN - 1755-1471

    IS - SUPPL. 8

    ER -